Skip to main content
  • Newsletters
  • Axios Pro
  • Axios Live
  • The Axios Show
Axios

Axios

Katherine Davis

Katherine Davis is a biotech reporter for Axios Pro Deals. She reports on venture capital, private equity and M&A transactions across the biotech sector.

  • email[email protected]

Stories

    • Biotech Deals

    11 hours ago

    Iambic Therapeutics aims to raise $150M in IPO

    Go deeper (1 min. read)
    • Biotech Deals

    Oct 7, 2026

    Biopharma dealmaking cools

    Go deeper (1 min. read)
    • Biotech Deals

    Oct 6, 2026

    Arboretum LifeSciences launches with $30M Series A

    Go deeper (1 min. read)
    • Biotech Deals

    Oct 5, 2026

    Exclusive: WhiteLab Genomics raises $26M Series B for AI-designed genomic medicines

    Go deeper (1 min. read)
    • Biotech Deals

    Oct 2, 2026

    Biotech IPOs face potential year-end slowdown

    Go deeper (1 min. read)

Newsletter editions

    • Newsletter

    Oct 3, 2026

    🧬 Biotech weekly

    Go deeper (4 min. read)
    • Newsletter

    Sep 26, 2026

    🧬 Biotech weekly

    Go deeper (5 min. read)
    • Newsletter

    May 16, 2026

    🧬 Biotech weekly

    Go deeper (2 min. read)
    • Newsletter

    May 9, 2026

    🧬 Biotech weekly

    Go deeper (4 min. read)
    • Newsletter

    May 7, 2026

    💭 Thought bubble: Biopharma buying binge

    Go deeper (1 min. read)
Smarter, faster on what matters.
Explore Axios Newsletters
  • About Axios
  • Advertise with us
  • Careers
  • Contact us
  • Newsletters
  • Axios Live
  • Axios HQ
  • Privacy policy
  • Terms of use
Axios Homepage

Axios Media Inc., 2026